Global private equity and venture capital news and research

Posts Tagged ‘Rosetta Capital’

18 February 2014

Rosetta Capital leads $66m Series B for Novimmune

drug-pharma-medical-healthcare London-based venture investor Rosetta Capital has led a CHF60m ($66m) Series B financing round for drug maker Novimmune.

13 February 2013

b-to-v Partners, Rosetta Capital acquires 13 companies from Karolinska Development

Swiss investment company b-to-v Partners and an investor syndicate led by London venture capital firm Rosetta Capital have jointly acquired stakes in 13 of Karolinska Development’s 25 portfolio companies for €30m.

Legals & Terms of UsePrivacy Policy

AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: WeWork 4001, 1 Fore Street, London, EC2Y 5EJ
Content is © AltAssets 2000-2016